Description: Peak Bio Co., Ltd. engages in developing drugs for the treatment of oncology and inflammatory diseases. The company was incorporated in 2015 and is based in Seongnam-si, South Korea.
Home Page: peak-bio.com
PKBO Technical Analysis
3350 W Bayshore Rd.
Palo Alto,
CA
94303
United States
Phone:
650-549-9103
Officers
| Name | Title |
|---|---|
| Dr. Hoyoung Huh M.D., Ph.D. | CEO & Exec. Chairman |
| Mr. Stephen LaMond PharmD MBA | COO, Sec. & Director |
| Dr. Satyajit Mitra Ph.D. | Head of Oncology & Exec. Director |
| Mr. Timothy M. Cunningham CPA, M.B.A. | Chief Financial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 252.1712 |
| IPO Date: | 2021-03-15 |
| Fiscal Year End: | December |
| Full Time Employees: | 30 |